Pubblicazioni Ricerche Riconoscimenti

Pubblicazioni. Ricerche. Riconoscimenti.

Pubblicazioni

Algorithm of the major and minor diagnostic criteria for active myopic choroidal neovascularization.

Milani P, Mazzola M, Cigada M, Massacesi A, Setaccioli M, Moschini S, Ciaccia S, Scotti F, Mantovani E, Soranna D, Zambon A, Bergamini F. Graefes Arch Clin Exp Ophthalmol. 2022 Sep;260(9):2847-2857

Comment on: Diagnostic algorithm utilising multimodal imaging including optical coherence tomography angiography for the detection of myopic choroidal neovascularization

Paolo Milani, Fabrizio Scotti, Fulvio Bergamini. Eye (Lond) 2021 Jan;35(1):349-350

Optical coherence tomography angiography features of sub retinal fibrosis after myopic neovascularization

Milani P, Pellegrini M, Massacesi A, Scotti F, Moschini S, Setaccioli M, Secondi R, Bergamini F.Retina. 2020 Feb;40(2):249-256.

Increased soluble urokinase plasminogen activator receptor (suPAR) levels in neovascular age-related macular degeneration: a role for inflammation in the pathogenesis of the disease?

Fabrizio Scotti, Paolo Milani, Marco Setaccioli, Silvia Maestroni, Nicolai Sidenius, Valentina De Lorenzi, Amedeo Massacesi, Fulvio Bergamini, Gianpaolo Zerbini. Graefes Arch Clin Exp Oph. 2019 Jan 7.

Optical coherence tomography features of subretinal fibrosis after myopic neovascularization.

P. Milani, M. Pellegrini, A. Massacesi,F. Scotti, S. Maschini, M. Setaccioli, R. Secondi, F. Bergamini. RETINA 00:1–8, 2018

Increased soluble urokinase Plasminogen Activator Receptor (suPAR) levels in age-related macular degeneration (AMD), a role for inflammation in the pathogenesis of the disease?

Massacesi, S. Moschini, P. Milani, M. Setaccioli, S. Maestroni, N. Sidenius, F. Bergamini, G. Zerbini. Euretina, Barcelona 2017

Chromogranin A fragmentation and pathogenesis of Age Related Macular Degeneration (AMD).

Scotti F, A. Massacesi S. Moschini M. Setaccioli C. Meoni F. Bergamini G. Zerbini Euretina, Copenaghen 2016

27-Gauge Vitrectomy for Primary Rhegmatogenous Retinal Detachment: Is it Feasible?

Romano MR, Scotti F, Vinciguerra P. Ann Acad Med Singapore. 2015 May;45(5):185-7.

Endothelial Progenitor Cells and response to Ranibizumab in Age-related macular Degeneration.

Scotti F, Maestroni A, Palini A, Introini U, Setaccioli M, Lorenzi M, Zerbini G. Retina. 2014 Sep;34(9):1802-10.

Intravitreal bevacizumab for Non-subfoveal Choroidal Neovascularization with angiod streaks.

Battaglia Parodi M, Iaconi P., C. La Spina, Berchicci L, Scotti F, Leyes A, Introini U, Bandello F. Am J Ophthalmol. 2014 Feb;157(2):374-377.

Inflammation and macula oedema after pars plana vitrectomy.

Romano V, Angi M, Scotti F, Del Grosso R, Romano D, Semeraro R, Vinciguerra P, Castigliola C, Romano MR. Mediators Inflamm. 2013; 2013;2013:971758. Review.

Intravitreal Bevacizumab for a Subfoveal Myopic Choroidal Neovascularization in the First Trimester of Pregnancy.

Introini U, Casalino G, Cardani A, Scotti F, Finardi A, Candiani M, Bandello F. J Ocul Pharmacol Ther. 2012 Oct;28(5):553-5. Epub 2012 Jun 4.

Spectral-domain OCT in anti-VEGF treatment of myopic choroidal neovascularization.

Introini U, Casalino G, Querques G, Gimeno AT, Scotti F, Bandello F. Eye (Lond). 2012 Jul;26(7):976-82.

SD-OCT patterns of the different stages of choroidal metastases.

Iuliano L, Scotti F, Gagliardi M, Bianchi I, Pierro L. Ophthalmic Surg Lasers Imaging. 2012 Mar 15;43 Online:e30-4

Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence.

Introini U, Torres Gimeno A, Scotti F, Setaccioli M, Giatsidis S, Bandello F. Graefes Arch Clin Exp Ophthalmol. 2012 Sep;250(9):1283-92.

Juxtafoveal choroidal neovascularization associated with retinitis pigmentosa treated with intravitreal bevacizumab.

Battaglia Parodi M, De Benedetto U, Knutsson KA, Scotti F, Librando A, Bandello F, Iacono P. J. Ocul Pharmacol Ther. 2012 Apr;28(2):202-4.

Intravitreal Ranibizumab And Exudative AMD Subtypes: Results In A Clinical Setting.

Introini U, Torres Gimeno A, Scotti F, Giatsidis S.M, Bandello F. Invest. Ophthalmol. Vis. Sci. 2012 (ARVO meeting).

Adverse Events After Dexamethasone Intravitreal Implant.

Scotti F, Zucchiatti I, Coscas F, Battaglia Parodi M, Casalino G, Lattanzio R, Coscas G, Bandello F. Invest. Ophthalmol. Vis. Sci. 2012 (ARVO meeting).

Rebound Effect After Intravitreal Dexamathasone Implant For The Treatment Of Macular Edema Secondary To Central Retinal Vein Occlusion.

De Benedetto U, Bataglia Pardi M, Iacono P, Prati M, Scotti F, Triolo G, Bandello F. Invest. Ophthalmol. Vis. Sci. 2012 (ARVO meeting).

Retro-Mode Imaging, Blue-Light Fundus Autofluorescence and Near-Infrared Fundus Autofluorescence in Retinal Dystrophies.

L. Berchicci, M. L. Cascavilla, C. La Spina, I.Bianchi, F. Scotti, M. Battaglia Parodi, P. Iacono, F. Bandello. Invest. Ophthalmol. Vis. Sci. 2012 (ARVO meeting).

Spectral-Domain Optical Coherence Tomography of Myopic Choroidal Neovascularization

U.Introini, M. Gagliardi, G. Casalino, L. Pierro, M. Setaccioli, F. Scotti, S. M. Giatsidis, F.M. Bandello. Invest. Ophthalmol. Vis. Sci. 2011, 52:2707 (ARVO meeting).

Retro-Mode Imaging, Blue-Light Fundus Autofluorescence and Near-Infrared Fundus Autofluorescence in Retinal Dystrophies.

L. Berchicci, M. L. Cascavilla, C. La Spina, I.Bianchi, F. Scotti, M. Battaglia Parodi, P. Iacono, F. Bandello. Invest. Ophthalmol. Vis. Sci. 2012 (ARVO meeting).

Blue Light And Near Infrared Fundus Autofluorescence In Best Vitelliform Macular Dystrophy.

C. Campa, M.Battaglia Parodi, A.Papayannis, P.Iacono, F. Scotti, M.Setaccioli, C. Del Turco, F. Bandello. Invest. Ophthalmol. Vis. Sci. 2011, 52:5012 (ARVO meeting).

Decreased Clonogenic Capacity of Endothelial Progenitor Cells (EPCs) in Age Related Macular Degeneration (AMD).

F. Scotti, A. Maestroni, S. Maestroni, U. Introini, M. Setaccioli, P. Rama, F. Bandello, M. Lorenzi, G. Zerbini. Invest. Ophthalmol. Vis. Sci. 2010, 51 : 2667 (ARVO meeting)

Retinal Angiomatous Proliferation (RAP) vs. Occult Choroidal Neovascularization (O-CNV) in Exudative Age-Related Macular Degeneration Evaluated With SD Optical Coherence Tomography (SDOCT) Before and After Ranibizumab Treatment.

M. Setaccioli, U. Introini, S.M. Giatsidis, A. Torres Gimeno, F. Scotti, L. Pierro, F. Bandello. Invest. Ophthalmol. Vis. Sci. 2010, 51 : 336. (ARVO meeting)

Spectral Domain Optical Coherence Tomography Evaluation of Macular Morphology Before and After Ranibizumab Treatment of Age-Related Macular Degeneration.

U. Introini, A. Torres Gimeno, M. Setaccioli, F. Scotti, S.M. Giatsidis, M. Gagliardi, L. Pierro, F. Bandello. Invest. Ophthalmol. Vis. Sci. 2010, 51 : 81 (ARVO meeting)

Spectral Domain Optical Coherence Tomography Evaluation of Macular Morphology After Antiangiogenic Treatment of Age-Related Macular Degeneration.

U. Introini, M. Setaccioli, F. Scotti, L. Pierro, S.M. Giatsidis, M. Gagliardi. Invest. Ophthalmol. Vis. Sci. 2009 50: 5252. (ARVO meeting)

Spectral OCT vs. Stratus OCT to Evaluate Macular Morphology in Wet Age Related Macular Degeneration.

S.M. Giatsidis, L.M. Pierro, M. Gagliardi, E. Mantovani, E. Zampedri, U. Introini, M. Setaccioli, F. Scotti. Invest. Ophthalmol. Vis. Sci. 2009, 50:5253. (ARVO meeting)

Spectral Domain OCT (SDOCT) versus Fluorescein Angiography (FA) in Wet Age Macular Degeneration (AMD) Evaluation.

L.M. Pierro, M. Gagliardi, S. Giatsidis, E. Mantovani, E. Zampedri, U. Introini, M. Setaccioli, F. Scotti. Invest. Ophthalmol. Vis. Sci. 2009, 50:5254. (ARVO meeting)

Elevated Erythropoietin and Vascular Endothelial Growth Factor levels in an Adolescent with Retinal Neovascularization from a chronic Rhegmatogenous Retinal Detachment.

J.B Kim, N.K Waheed, M. Romano M., F. Scotti., A. Hafezi-Moghadam, DJ D’Amico. Retinal cases & Brief reports, 2008;2:117-120

Combined Intravitreal Ranibizumab and Verteporfin Photodynamic Therapy for Choroidal Neovascularization in Angioid Streaks: Preliminary Results.

U. Introini, M. Setaccioli, F. Scotti, A. Ramoni, and M. gagliardi. Invest. Ophthalmol. Vis. Sci. 2008 49: 3452. (ARVO meeting)

Macular Hole and Intravitreal Injection of Triamcinolone Acetonide for Macular Edema due to Central Retinal Vein Occlusion.

R. Lattanzio, A. Ramoni, F. Scotti, U. Introini. European Journal of ophthalmology, 2007; 3:451-453

Computed Tomography and Magnetic Resonance Imaging of Anecortave Acetate After Posterior Juxtascleral Injection in the Rabbit.

S. M. Warden, J.B. Christoforidis, P.A. Caruso, M. Romano, F.Scotti , D. J. D’Amico. Invest. Ophthalmol. Vis. Sci. 2007, 48:5819 (ARVO meeting)

Intravitreal Bevacizumab Injection for Retinal Pigment Epithelial tears in AMD: preliminary results.

U.Introini, M.Setaccioli, F.Scotti, M.Gagliardi, A.Ramoni. Invest. Ophthalmol. Vis. Sci. 2007, 48 :293. (ARVO meeting)

Intravitreal Triamcilonone acetonide (IVTA) injection alone or combined with PDT for vascularized retinal pigment epithelial detachments (V-PED) in AMD.

U. Introini, M. Setaccioli, M. Gagliardi, A. Ramoni, F.Scotti, R. Brancato. Invest. Ophthalmol. Vis. Sci. 2006, 47: 4275

Baseline OCT Findings and Visual Acuity in the Combined Treatment of Retinal Angiomatous Proliferations With IVTA and PDT: Two Prognostic Factors.

M. Setaccioli, U. Introini, M. Gagliardi, A. Ramoni, F.Scotti, R. Brancato. Invest. Ophthalmol. Vis. Sci. 2006, 47: 4289

Efficacy of intravitreal triamcilonone acetonide (IVTA) injections in chronic macular edema in diabetic retinopathy (DR) vs central retinal vein occlusion (CRVO).

R.Lattanzio, A. Ramoni, E. Bruschi, G.Tremolada, F.Scotti, S.Donati, U.Introini, L.Pierro, R.Brancato. Invest. Ophthalmol. Vis. Sci. 2005, 46: 1430 (ARVO meeting)

Diabetic Macular Edema : Juxtascleral (JS) versus Intravitreal (IV) Triamcinolone Acetonide (TA) Injections.

U.Introini, M.Setaccioli, A .Ramoni, F.Scotti, S.Donati, R.Brancato. Invest. Ophthalmol. Vis. Sci. 2005, 46:281 (ARVO meeting)

Treatment of extrafoveal choroidal neovascularization in pathological myopia with photodynamic therapy – two year results.

R. Brancato, R. Lattanzio, G. Tremolada, F. Scotti, S. Donati, L. Pierro, U. Introini, G. Modorati, and E. Miserocchi. Invest. Ophthalmol. Vis. Sci. 2005, 46:342 (ARVO meeting)

Ricerche